ANGIBAUD PATRICK RENE has a total of 12 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are SYNTEX PHARMA LTD, LEAD DISCOVERY CENTER GMBH and CHAO YU-SHENG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Angibaud Patrick Rene | 12 |
#2 | Pilatte Isabelle Noelle Constance | 4 |
#3 | Roux Bruno | 4 |
#4 | Arts Janine | 3 |
#5 | Venet Marc Gaston | 3 |
#6 | Van Emelen Kristof | 3 |
#7 | Marconnet-Decrane Laurence Francoise Bernadette | 3 |
#8 | Mevellec Laurence Anne | 3 |
#9 | Van Brandt Sven Franciscus Anna | 2 |
#10 | Poncelet Virginie Sophie | 2 |
Publication | Filing date | Title |
---|---|---|
US2010222348A1 | Quinolinone derivatives as PARP inhibitors | |
US2009018152A1 | Aminophenyl derivatives as novel inhibitors of histone deacetylase | |
WO0039082A2 | 1,2-annelated quinoline derivatives |